LuxExperience — parent company of Mytheresa, Net-a-Porter, Mr Porter, Yoox and The Outnet — said net sales grew 8.9 per cent ...
Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Designation earned for one-time AAV gene therapy SAR446268, designed to silence DMPK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback